[*] Certain information in this document has been omitted from this exhibit because it is both (i) not materialand (ii) would be competitively harmful if publicly disclosed.
April 7, 2021
NOTICE OF AWARD
Office of Sponsored Programs
University of Texas MD Anderson Cancer Center
1515 Holcombe Boulevard
Houston, Texas 77030
(713) 792 3220
Financial Department Kiromic BioPharma, Inc.
Fannin South Professioral Building,
Houston, Texas 77054
(832) 968 4888
Title of Grant: Validation of biomarker isomeso for pancreatic cancer We are providing this letter of intent for a contract which is to be awarded to: Professor Robert S. Bresalier M.D.
Department of Gastroenterology, Hepatology and Nutrition (Principle Investigator), the
University of Texas MD Anderson Cancer Center for conduct of the above: research grant.
MD Anderson is a member institution of the University of Texas System, and as such, is a government agency of the State of Texas, which under the Constitution and the laws of the state of Texas possess certain rights and privileges, is subject to certain Imitations and restrictions, and only has such authority as is granted under the Constitution and laws of the State of Texas. Notwithstanding any provision hereof, nothing in this gran: agreement is intended to be, nor will it be construed to be, a waiver of the sovereign im11unity of the State of Texas or a prospective waiver or restriction of any of the rights, remedies, claims, and privileges of the State of Texas.
/s/ Tony Tontat
Tony Tontat – Chief Financial Officer of Kiromic BioPharma, Inc